Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
The delays in Alzheimer’s research is one example of how millions of dollars in research have been stalled as NIH grapples ...
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
The Alzheimer’s Disease Research Center (ADRC) at the University of Pittsburgh is one of the country’s hubs for researchers ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...
What Gutting NIH Research Means for Americans with Cancer, Alzheimer's, & Other Diseases” will spotlight patients, ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...